Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging
Published on: March 22, 2024
Drug-Resistant Gram-Positive Cocci as Etiological Factors of Cardiac Implantable Electronic Device Infections-Data
Danuta Łoboda1,2, Sylwia Gładysz-Wańha2,3, Michał Joniec2,3
1Department of Electrocardiology and Heart Failure, Medical University of Silesia, 40-635 Katowice, Poland.
Introduction:
Bacterial multidrug resistance (MDR) drives treatment with expensive, toxic, or pharmacokinetically suboptimal antibiotics.
Objectives:
To assess the prevalence of MDR Gram-positive cocci among isolates from cardiac implantable electronic device (CIED) infections at a Polish reference center.
Methods:
Data come from the "EXTRACT" registry (ClinicalTrials.gov ID NCT05775783), which covers 702 transvenous lead extraction procedures. Blood samples and intraoperative swabs were collected from participants with CIED infection.
Results:
From 209 cases with isolated pocket infection (PI) (107, 51.2%) or systemic infections (102, 48.8%), 263 Gram-positive cocci were cultured. They were: coagulase-negative staphylococci (CoNS) (177, 67.3%), Staphylococcus aureus (62, 23.6%), enterococci (15, 5.7%), streptococci (8, 3.0%), and others (1, 0.4%). The highest MDR rate was among CoNS (46.9%). CoNS exhibited methicillin resistance (MR-CoNS) in 55.9% with co-resistance to macrolides (73.2%), lincosamides (51.0%), fluoroquinolones (56.1%), aminoglycosides (41.4%), tetracyclines (29.6%), and co-trimoxazole (29.3%). Resistance to daptomycin (5.3%) and linezolid (2.0%) in MR-CoNS was rare. The frequency of MDR S. aureus was 8.1%. Methicillin resistance in S. aureus (MRSA, 6.5%) co-occurred with resistance to macrolides/lincosamides and fluoroquinolones (100% for both) or linezolid (25.0%). All MDR staphylococci were vancomycin-susceptible. High-level aminoglycoside resistance (HLAR) in Enterococcus faecalis (53.8%) was accompanied by levofloxacin co-resistance (66.7%). Conversely, E. faecium HLAR (50.0%) strains showed 100.0% β-lactam resistance. Vancomycin-resistant enterococci (VRE) accounted for 6.7%; the VRE E. faecium strain was tigecycline- and linezolid-susceptible. Among viridans group streptococci, β-lactam and lincosamides resistance was common (40.0% for both), with 50.0% of co-resistance.
Conclusions:
Epidemiological data may improve the effectiveness of empirical antibiotic therapy for CIED-related infections.
Insights
Multidrug resistance (MDR) is high in Gram-positive cocci causing cardiac implantable electronic device (CIED) infections, particularly in coagulase-negative staphylococci. This highlights the need for updated empirical antibiotic strategies for CIED infections.
Area of Science:
- Infectious Diseases
- Medical Microbiology
- Cardiology
Background:
- Bacterial multidrug resistance (MDR) complicates treatment choices for infections, often necessitating the use of antibiotics with significant toxicity or suboptimal pharmacokinetic profiles.
- Cardiac implantable electronic device (CIED) infections pose a serious threat, and the emergence of antibiotic-resistant bacteria presents a growing challenge in their management.
Purpose of the Study:
- To determine the prevalence of multidrug-resistant (MDR) Gram-positive cocci isolated from patients with CIED infections.
- To analyze the specific resistance patterns of key bacterial species, including staphylococci and enterococci, within this patient population.
Main Methods:
- Data were sourced from the 'EXTRACT' registry (ClinicalTrials.gov ID NCT05775783), involving 702 transvenous lead extraction procedures.
- Microbiological analysis included cultures from blood samples and intraoperative swabs of patients diagnosed with CIED infections.
Main Results:
- Coagulase-negative staphylococci (CoNS) were the most frequently isolated Gram-positive cocci (67.3%), exhibiting the highest MDR rates (46.9%), including high prevalence of methicillin resistance (MR-CoNS).
- Methicillin-resistant CoNS showed significant co-resistance to macrolides, lincosamides, fluoroquinolones, and aminoglycosides, though resistance to daptomycin and linezolid was infrequent.
- MDR Staphylococcus aureus (MRSA) was less common (8.1%), with high co-resistance to certain antibiotic classes. Vancomycin resistance was not observed in MDR staphylococci. High-level aminoglycoside resistance (HLAR) was noted in enterococci, with varying co-resistance patterns depending on the species (E. faecalis vs. E. faecium).
Conclusions:
- The high prevalence of MDR Gram-positive cocci, especially MR-CoNS, in CIED infections necessitates careful consideration in empirical antibiotic selection.
- Understanding local epidemiological data on antibiotic resistance is crucial for optimizing treatment strategies and improving outcomes for patients with CIED-related infections.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Endocarditis I: Introduction
Bacterial Signaling
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Endocarditis III: Medical Management

